Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins

Cell Reports

Volumn 15, Issue 2, 2016, Pages 349-359

  Zhang, Wenwei ^a,b   Bu, So Young ^c,d   Mashek, Mara T ^c,d   O Sullivan, InSug ^a,b   Sibai, Zakaria ^a,b   Khan, Salmaan A ^c,d   Ilkayeva, Olga ^e,f   Newgard, Christopher B ^e,f   Mashek, Douglas G ^c,d   Unterman, Terry G ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e DUKE UNIVERSITY   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TRIACYLGLYCEROL LIPASE; APOLIPOPROTEIN B; CARNITINE PALMITOYLTRANSFERASE I; GLUCOKINASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; CELL CYCLE PROTEIN; FATTY ACID; FOXO1 PROTEIN, MOUSE; G0S2 PROTEIN, MOUSE; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; G0S2 GENE; GENE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; IN VIVO STUDY; INTRAHEPATIC LIPOLYSIS; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER CELL; LIVER METABOLISM; MALE; METABOLIC REGULATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PEPCK GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; HUMAN; LIVER; METABOLISM; OXIDATION REDUCTION REACTION;

ADIPOSE TISSUE; ANIMALS; CELL CYCLE PROTEINS; FATTY ACIDS; FORKHEAD BOX PROTEIN O1; GENE EXPRESSION REGULATION; GLUCOSE; HEPATOCYTES; HOMEOSTASIS; HUMANS; LIPASE; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; OXIDATION-REDUCTION;

EID: 84962082073     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.03.021     Document Type: Article

References (47)

1. An J., Muoio D.M., Shiota M., Fujimoto Y., Cline G.W., Shulman G.I., Koves T.R., Stevens R., Millington D., Newgard C.B. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 2004, 10:268-274.
2. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
3. Brown J.M., Betters J.L., Lord C., Ma Y., Han X., Yang K., Alger H.M., Melchior J., Sawyer J., Shah R., et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J. Lipid Res. 2010, 51:3306-3315.
4. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
5. Bu S.Y., Mashek M.T., Mashek D.G. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 2009, 284:30474-30483.
6. Chakrabarti P., Kandror K.V. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J. Biol. Chem. 2009, 284:13296-13300.
7. Chakrabarti P., Kim J.Y., Singh M., Shin Y.K., Kim J., Kumbrink J., Wu Y., Lee M.J., Kirsch K.H., Fried S.K., Kandror K.V. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol. Cell. Biol. 2013, 33:3659-3666.
8. Coleman R.A., Mashek D.G. Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling. Chem. Rev. 2011, 111:6359-6386.
9. Daitoku H., Yamagata K., Matsuzaki H., Hatta M., Fukamizu A. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 2003, 52:642-649.
10. Dong X.C., Copps K.D., Guo S., Li Y., Kollipara R., DePinho R.A., White M.F. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 2008, 8:65-76.
11. Freedman A.D., Kohn L. Pyruvate metabolism and control: factors affecting pyruvic carboxylase activity. Science 1964, 145:58-60.
12. Ganjam G.K., Dimova E.Y., Unterman T.G., Kietzmann T. FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol. J. Biol. Chem. 2009, 284:30783-30797.
13. Garland P.B., Randle P.J. Control of pyruvate dehydrogenase in the perfused rat heart by the intracellular concentration of acetyl-coenzyme A. Biochem. J. 1964, 91:6C-7C.
14. Haemmerle G., Moustafa T., Woelkart G., Büttner S., Schmidt A., van de Weijer T., Hesselink M., Jaeger D., Kienesberger P.C., Zierler K., et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat. Med. 2011, 17:1076-1085.
15. Haeusler R.A., Hartil K., Vaitheesvaran B., Arrieta-Cruz I., Knight C.M., Cook J.R., Kammoun H.L., Febbraio M.A., Gutierrez-Juarez R., Kurland I.J., Accili D. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat. Commun. 2014, 5:5190.
16. Hall R.K., Yamasaki T., Kucera T., Waltner-Law M., O'Brien R., Granner D.K. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J. Biol. Chem. 2000, 275:30169-30175.
17. Heckmann B.L., Zhang X., Xie X., Liu J. The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond. Biochim. Biophys. Acta 2013, 1831:276-281.
18. Hirota K., Daitoku H., Matsuzaki H., Araya N., Yamagata K., Asada S., Sugaya T., Fukamizu A. Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. J. Biol. Chem. 2003, 278:13056-13060.
19. Hirota K., Sakamaki J., Ishida J., Shimamoto Y., Nishihara S., Kodama N., Ohta K., Yamamoto M., Tanimoto K., Fukamizu A. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J. Biol. Chem. 2008, 283:32432-32441.
20. Hue L., Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E578-E591.
21. Khan S.A., Sathyanarayan A., Mashek M.T., Ong K.T., Wollaston-Hayden E.E., Mashek D.G. ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling. Diabetes 2015, 64:418-426.
22. Kienesberger P.C., Lee D., Pulinilkunnil T., Brenner D.S., Cai L., Magnes C., Koefeler H.C., Streith I.E., Rechberger G.N., Haemmerle G., et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J. Biol. Chem. 2009, 284:30218-30229.
23. Lewis G.F., Vranic M., Harley P., Giacca A. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 1997, 46:1111-1119.
24. Lian J., Wei E., Wang S.P., Quiroga A.D., Li L., Di Pardo A., van der Veen J., Sipione S., Mitchell G.A., Lehner R. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice. Hepatology 2012, 56:2154-2162.
25. Mullins G.R., Wang L., Raje V., Sherwood S.G., Grande R.C., Boroda S., Eaton J.M., Blancquaert S., Roger P.P., Leitinger N., Harris T.E. Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes. Proc. Natl. Acad. Sci. USA 2014, 111:17450-17455.
26. Nauli A.M., Nassir F., Zheng S., Yang Q., Lo C.M., Vonlehmden S.B., Lee D., Jandacek R.J., Abumrad N.A., Tso P. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 2006, 131:1197-1207.
27. O-Sullivan I., Zhang W., Wasserman D.H., Liew C.W., Liu J., Paik J., DePinho R.A., Stolz D.B., Kahn C.R., Schwartz M.W., Unterman T.G. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat. Commun. 2015, 6:7079.
28. Ong K.T., Mashek M.T., Bu S.Y., Greenberg A.S., Mashek D.G. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 2011, 53:116-126.
29. Ong K.T., Mashek M.T., Bu S.Y., Mashek D.G. Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. FASEB J. 2013, 27:313-321.
30. Perry R.J., Camporez J.P., Kursawe R., Titchenell P.M., Zhang D., Perry C.J., Jurczak M.J., Abudukadier A., Han M.S., Zhang X.M., et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015, 160:745-758.
31. Sapiro J.M., Mashek M.T., Greenberg A.S., Mashek D.G. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity. J. Lipid Res. 2009, 50:1621-1629.
32. Satapati S., Sunny N.E., Kucejova B., Fu X., He T.T., Méndez-Lucas A., Shelton J.M., Perales J.C., Browning J.D., Burgess S.C. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 2012, 53:1080-1092.
33. Tang T., Abbott M.J., Ahmadian M., Lopes A.B., Wang Y., Sul H.S. Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells. Cell Metab. 2013, 18:883-895.
34. Titchenell P.M., Chu Q., Monks B.R., Birnbaum M.J. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nat. Commun. 2015, 6:7078.
35. Turpin S.M., Hoy A.J., Brown R.D., Rudaz C.G., Honeyman J., Matzaris M., Watt M.J. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 2011, 54:146-156.
36. Wang Y., Zhang Y., Qian H., Lu J., Zhang Z., Min X., Lang M., Yang H., Wang N., Zhang P. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism. PLoS ONE 2013, 8:e72315.
37. Williamson J.R., Kreisberg R.A., Felts P.W. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. Natl. Acad. Sci. USA 1966, 56:247-254.
38. Wolfe R.R., Peters E.J. Lipolytic response to glucose infusion in human subjects. Am. J. Physiol. 1987, 252:E218-E223.
39. Xiong X., Tao R., DePinho R.A., Dong X.C. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis. PLoS ONE 2013, 8:e74340.
40. Yang X., Lu X., Lombès M., Rha G.B., Chi Y.I., Guerin T.M., Smart E.J., Liu J. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab. 2010, 11:194-205.
41. Yeagley D., Guo S., Unterman T., Quinn P.G. Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences. J. Biol. Chem. 2001, 276:33705-33710.
42. Zechner R., Kienesberger P.C., Haemmerle G., Zimmermann R., Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res. 2009, 50:3-21.
43. Zhang K., Li L., Qi Y., Zhu X., Gan B., DePinho R.A., Averitt T., Guo S. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 2012, 153:631-646.
44. Zhang W., Patil S., Chauhan B., Guo S., Powell D.R., Le J., Klotsas A., Matika R., Xiao X., Franks R., et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 2006, 281:10105-10117.
45. Zhang X., Xie X., Heckmann B.L., Saarinen A.M., Czyzyk T.A., Liu J. Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis. Diabetes 2014, 63:934-946.
46. Zhao X., Gan L., Pan H., Kan D., Majeski M., Adam S.A., Unterman T.G. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem. J. 2004, 378:839-849.
47. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306:1383-1386.